FSG — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

Aplagonaplagon.com inFeb 2025

Aplagon is a clinical-stage biopharmaceutical company developing first-in-class therapeutics targeting thromboinflammatory and cardiovascular diseases.

BiotechHealthtechMedical DevicesHelsinki, FI

Sakari Lassila(Founder)in

Co-investorsInnovestor Ventures Invesdor Innovestor

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.